Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Gene-Edited Treatments in Works for Safer Cancer Therapies

T-cells and cancer cells

A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies

Pharma, Synthetic Bio Companies to Find Antibody Therapies

DNA chip graphic

A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies

Health Journals Call for Emergency Climate Action

Climate change skyline

An editorial published in more than 200 journals calls for governments worldwide to take immediate action to mitigate climate changes affecting public health. . . . → Read More: Health Journals Call for Emergency Climate Action

Biotechs Partner on Agitation Detection Technology

Sad, depressed

Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders. . . . → Read More: Biotechs Partner on Agitation Detection Technology

Trial Shows Synthetic Antibody Slows Cognitive Decline

neurons

Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease. . . . → Read More: Trial Shows Synthetic Antibody Slows Cognitive Decline

Biotechs Partner on Synthetic Plant-Based Drugs

Two biotechnology companies are designing new processes to produce ingredients much like those found in drugs made from plants for essential medicines. . . . → Read More: Biotechs Partner on Synthetic Plant-Based Drugs

Moderna to Build mRNA Vaccine Plant in Canada

Syringes

The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada

Sanofi Acquires mRNA Developer in $3.2B Deal

Wall Street sign

Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator. . . . → Read More: Sanofi Acquires mRNA Developer in $3.2B Deal

Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal

Brain activity graphic

A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases. . . . → Read More: Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal

Pharma, Biotech Partner on Off-the-Shelf Cell Therapies

Mitochondria illustration

A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells. . . . → Read More: Pharma, Biotech Partner on Off-the-Shelf Cell Therapies